Reducing hospital readmission rates among schizophrenics

Area of Science:

• Psychiatry
• Clinical Pharmacology

Background:

• Schizophrenia often requires long-term neuroleptic medication for remission.
• Inpatient care is common, with discharge following initial improvement on medication.

Purpose of the Study:

• To evaluate the effectiveness of depot phenothiazine in reducing hospitalizations.
• To assess the impact of antipsychotic medication on schizophrenia patient outcomes.

Main Methods:

• A mirror-image study design was employed, using patients as their own controls.
• Hospitalization rates were compared before and after the introduction of depot phenothiazine.

Main Results:

• Depot phenothiazine administration led to highly significant reductions in patient hospitalizations.
• The study demonstrated a clear benefit of this long-acting injectable antipsychotic.

Conclusions:

• Vigorous outpatient follow-up is essential for maintaining remission in schizophrenia.
• The cost of a well-staffed outpatient clinic is considerably lower than the cost of hospitalization.